Vhlh Gene Deletion Induces Hif-1-Mediated Cell Death in Thymocytes

REFERENCES

• Adelman, D. M., Gertsenstein M., Nagy A., Simon M. C., and Maltepe E.. 2000. Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev. 14:3191–3203.
   PubMed Web of Science ®Google Scholar
• Ang, S. O., Chen H., Hirota K., Gordeuk V. R., Jelinek J., Guan Y., Liu E., Sergueeva A. I., Miasnikova G. Y., Mole D., Maxwell P. H., Stockton D. W., Semenza G. L., and Prchal J. T.. 2002. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat. Genet. 32:614–621.
   PubMed Web of Science ®Google Scholar
• Bouillet, P., Metcalf D., Huang D. C., Tarlinton D. M., Kay T. W., Kontgen F., Adams J. M., and Strasser A.. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735–1738.
   PubMed Web of Science ®Google Scholar
• Bruick, R. K. 2000. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. USA 97:9082–9087.
   PubMed Web of Science ®Google Scholar
• Caldwell, C. C., Kojima H., Lukashev D., Armstrong J., Farber M., Apasov S. G., and Sitkovsky M. V.. 2001. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J. Immunol. 167:6140–6149.
   PubMed Web of Science ®Google Scholar
• Camenisch, G., Wenger R. H., and Gassmann M.. 2002. DNA-binding activity of hypoxia-inducible factors (HIFs). Methods Mol. Biol. 196:117–129.
   PubMedGoogle Scholar
• Carmeliet, P., Dor Y., Herbert J. M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C. J., Ratcliffe P., Moons L., Jain R. K., Collen D., Keshert E., and Keshet E.. 1998. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485–490.
   PubMed Web of Science ®Google Scholar
• Chao, D. T., Linette G. P., Boise L. H., White L. S., Thompson C. B., and Korsmeyer S. J.. 1995. Bcl-XL and Bcl-2 repress a common pathway of cell death. J. Exp. Med. 182:821–828.
   PubMed Web of Science ®Google Scholar
• Chao, W., Shen Y., Li L., and Rosenzweig A.. 2002. Importance of FADD signaling in serum deprivation- and hypoxia-induced cardiomyocyte apoptosis. J. Biol. Chem. 277:31639–31645.
   PubMed Web of Science ®Google Scholar
• Chinnaiyan, A. M., O'Rourke K., Tewari M., and Dixit V. M.. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505–512.
   PubMed Web of Science ®Google Scholar
• Cramer, T., Yamanishi Y., Clausen B. E., Forster I., Pawlinski R., Mackman N., Haase V. H., Jaenisch R., Corr M., Nizet V., Firestein G. S., Gerber H. P., Ferrara N., and Johnson R. S.. 2003. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112:645–657.
   PubMed Web of Science ®Google Scholar
• Epstein, A. C., Gleadle J. M., McNeill L. A., Hewitson K. S., O'Rourke J., Mole D. R., Mukherji M., Metzen E., Wilson M. I., Dhanda A., Tian Y. M., Masson N., Hamilton D. L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P. H., Pugh C. W., Schofield C. J., and Ratcliffe P. J.. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43–54.
   PubMed Web of Science ®Google Scholar
• Galbán, S., Fan J., Martindale J. L., Cheadle C., Hoffman B., Woods M. P., Temeles G., Brieger J., Decker J., and Gorospe M.. 2003. von Hippel-Lindau protein-mediated repression of tumor necrosis factor alpha translation revealed through use of cDNA arrays. Mol. Cell. Biol. 23:2316–2328.
   PubMedGoogle Scholar
• Gervais, F. G., Singaraja R., Xanthoudakis S., Gutekunst C. A., Leavitt B. R., Metzler M., Hackam A. S., Tam J., Vaillancourt J. P., Houtzager V., Rasper D. M., Roy S., Hayden M. R., and Nicholson D. W.. 2002. Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat. Cell Biol. 4:95–105.
   PubMedGoogle Scholar
• Gnarra, J. R., Ward J. M., Porter F. D., Wagner J. R., Devor D. E., Grinberg A., Emmert-Buck M. R., Westphal H., Klausner R. D., and Linehan W. M.. 1997. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc. Natl. Acad. Sci. USA 94:9102–9107.
   PubMed Web of Science ®Google Scholar
• Gratiot-Deans, J., Merino R., Nunez G., and Turka L. A.. 1994. Bcl-2 expression during T-cell development: early loss and late return occur at specific stages of commitment to differentiation and survival. Proc. Natl. Acad. Sci. USA 91:10685–10689.
   PubMedGoogle Scholar
• Gross, A., McDonnell J. M., and Korsmeyer S. J.. 1999. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1899–1911.
   PubMed Web of Science ®Google Scholar
• Gurevich, R. M., Regula K. M., and Kirshenbaum L. A.. 2001. Serpin protein CrmA suppresses hypoxia-mediated apoptosis of ventricular myocytes. Circulation 103:1984–1991.
   PubMedGoogle Scholar
• Haase, V. H., Glickman J. N., Socolovsky M., and Jaenisch R.. 2001. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc. Natl. Acad. Sci. USA 98:1583–1588.
   PubMed Web of Science ®Google Scholar
• Hale, L. P., Braun R. D., Gwinn W. M., Greer P. K., and Dewhirst M. W.. 2002. Hypoxia in the thymus: role of oxygen tension in thymocyte survival. Am. J. Physiol. Heart Circ. Physiol. 282:H1467–H1477.
   PubMedGoogle Scholar
• Harris, A. L. 2002. Hypoxia—a key regulatory factor in tumour growth. Nat. Rev. Cancer 2:38–47.
   PubMed Web of Science ®Google Scholar
• Hergovich, A., Lisztwan J., Barry R., Ballschmieter P., and Krek W.. 2003. Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat. Cell Biol. 5:64–70.
   PubMed Web of Science ®Google Scholar
• Herman, J. G., Latif F., Weng Y., Lerman M. I., Zbar B., Liu S., Samid D., Duan D. S., Gnarra J. R., Linehan W. M., et al. 1994. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 91:9700–9704.
   PubMed Web of Science ®Google Scholar
• Ivan, M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J. M., Lane W. S., and Kaelin W. G., Jr. 2001. HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292:464–468.
   PubMed Web of Science ®Google Scholar
• Iwai, K., Yamanaka K., Kamura T., Minato N., Conaway R. C., Conaway J. W., Klausner R. D., and Pause A.. 1999. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc. Natl. Acad. Sci. USA 96:12436–12441.
   PubMed Web of Science ®Google Scholar
• Iyer, N. V., Kotch L. E., Agani F., Leung S. W., Laughner E., Wenger R. H., Gassmann M., Gearhart J. D., Lawler A. M., Yu A. Y., and Semenza G. L.. 1998. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α. Genes Dev. 12:149–162.
   PubMed Web of Science ®Google Scholar
• Jaakkola, P., Mole D. R., Tian Y. M., Wilson M. I., Gielbert J., Gaskell S. J., Kriegsheim A., Hebestreit H. F., Mukherji M., Schofield C. J., Maxwell P. H., Pugh C. W., and Ratcliffe P. J.. 2001. Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468–472.
   PubMed Web of Science ®Google Scholar
• Jiang, D., Zheng L., and Lenardo M. J.. 1999. Caspases in T-cell receptor-induced thymocyte apoptosis. Cell Death Differ. 6:402–411.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G., Jr. 2002. Molecular basis of the VHL hereditary cancer syndrome. Nat. Rev. Cancer 2:673–682.
   PubMed Web of Science ®Google Scholar
• Kojima, H., Gu H., Nomura S., Caldwell C. C., Kobata T., Carmeliet P., Semenza G. L., and Sitkovsky M. V.. 2002. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice. Proc. Natl. Acad. Sci. USA 99:2170–2174.
   PubMed Web of Science ®Google Scholar
• Laird, P. W., Zijderveld A., Linders K., Rudnicki M. A., Jaenisch R., and Berns A.. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:4293.
   PubMed Web of Science ®Google Scholar
• Latif, F., Tory K., Gnarra J., Yao M., Duh F. M., Orcutt M. L., Stackhouse T., Kuzmin I., Modi W., Geil L., et al. 1993. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317–1320.
   PubMed Web of Science ®Google Scholar
• Lee, P. P., Fitzpatrick D. R., Beard C., Jessup H. K., Lehar S., Makar K. W., Perez-Melgosa M., Sweetser M. T., Schlissel M. S., Nguyen S., Cherry S. R., Tsai J. H., Tucker S. M., Weaver W. M., Kelso A., Jaenisch R., and Wilson C. B.. 2001. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15:763–774.
   PubMed Web of Science ®Google Scholar
• Ma, A., Pena J. C., Chang B., Margosian E., Davidson L., Alt F. W., and Thompson C. B.. 1995. Bclx regulates the survival of double-positive thymocytes. Proc. Natl. Acad. Sci. USA 92:4763–4767.
   PubMed Web of Science ®Google Scholar
• Makino, Y., Nakamura H., Ikeda E., Ohnuma K., Yamauchi K., Yabe Y., Poellinger L., Okada Y., Morimoto C., and Tanaka H.. 2003. Hypoxia-inducible factor regulates survival of antigen receptor-driven T cells. J. Immunol. 171:6534–6540.
   PubMed Web of Science ®Google Scholar
• Malhotra, R., Lin Z., Vincenz C., and Brosius III F. C.. 2001. Hypoxia induces apoptosis via two independent pathways in Jurkat cells: differential regulation by glucose. Am. J. Physiol. Cell Physiol. 281:C1596–C1603.
   PubMedGoogle Scholar
• Maltepe, E., Schmidt J. V., Baunoch D., Bradfield C. A., and Simon M. C.. 1997. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386:403–407.
   PubMed Web of Science ®Google Scholar
• Maxwell, P. H., Wiesener M. S., Chang G. W., Clifford S. C., Vaux E. C., Cockman M. E., Wykoff C. C., Pugh C. W., Maher E. R., and Ratcliffe P. J.. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275.
   PubMed Web of Science ®Google Scholar
• Micheau, O., Solary E., Hammann A., and Dimanche-Boitrel M. T.. 1999. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J. Biol. Chem. 274:7987–7992.
   PubMed Web of Science ®Google Scholar
• Ohh, M., Park C. W., Ivan M., Hoffman M. A., Kim T. Y., Huang L. E., Pavletich N., Chau V., and Kaelin W. G.. 2000. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2:423–427.
   PubMed Web of Science ®Google Scholar
• Ohh, M., Yauch R. L., Lonergan K. M., Whaley J. M., Stemmer-Rachamimov A. O., Louis D. N., Gavin B. J., Kley N., Kaelin W. G., Jr., and Iliopoulos O.. 1998. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol. Cell 1:959–968.
   PubMed Web of Science ®Google Scholar
• Opferman, J. T., and Korsmeyer S. J.. 2003. Apoptosis in the development and maintenance of the immune system. Nat. Immunol. 4:410–415.
   PubMed Web of Science ®Google Scholar
• Pfander, D., Kobayashi T., Knight M. C., Zelzer E., Chan D. A., Olsen B. R., Giaccia A. J., Johnson R. S., Haase V. H., and Schipani E.. 2004. Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development. Development 131:2497–2508.
   PubMed Web of Science ®Google Scholar
• Pugh, C. W., and Ratcliffe P. J.. 2003. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9:677–684.
   PubMed Web of Science ®Google Scholar
• Rathmell, J. C., and Thompson C. B.. 1999. The central effectors of cell death in the immune system. Annu. Rev. Immunol. 17:781–828.
   PubMed Web of Science ®Google Scholar
• Richards, F. M., Crossey P. A., Phipps M. E., Foster K., Latif F., Evans G., Sampson J., Lerman M. I., Zbar B., Affara N. A., et al. 1994. Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene. Hum. Mol. Genet. 3:595–598.
   PubMed Web of Science ®Google Scholar
• Ryan, H. E., Lo J., and Johnson R. S.. 1998. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17:3005–3015.
   PubMed Web of Science ®Google Scholar
• Ryan, H. E., Poloni M., McNulty W., Elson D., Gassmann M., Arbeit J. M., and Johnson R. S.. 2000. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth. Cancer Res. 60:4010–4015.
   PubMed Web of Science ®Google Scholar
• Rytomaa, M., Martins L. M., and Downward J.. 1999. Involvement of FADD and caspase-8 signalling in detachment-induced apoptosis. Curr. Biol. 9:1043–1046.
   PubMed Web of Science ®Google Scholar
• Salceda, S., and Caro J.. 1997. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions: its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272:22642–22647.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., and Russell D. W.. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, New York, N.Y.
   Google Scholar
• Sanchez, I., Xu C. J., Juo P., Kakizaka A., Blenis J., and Yuan J.. 1999. Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22:623–633.
   PubMed Web of Science ®Google Scholar
• Scortegagna, M., Ding K., Oktay Y., Gaur A., Thurmond F., Yan L. J., Marck B. T., Matsumoto A. M., Shelton J. M., Richardson J. A., Bennett M. J., and Garcia J. A.. 2003. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1−/− mice. Nat. Genet. 35:331–340.
   PubMedGoogle Scholar
• Sebzda, E., Mariathasan S., Ohteki T., Jones R., Bachmann M. F., and Ohashi P. S.. 1999. Selection of the T cell repertoire. Annu. Rev. Immunol. 17:829–874.
   PubMed Web of Science ®Google Scholar
• Semenza, G. L. 2001. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 13:167–171.
   PubMed Web of Science ®Google Scholar
• Sheikh, M. S., Antinore M. J., Huang Y., and Fornace A. J., Jr. 1998. Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1. Oncogene 17:2555–2563.
   PubMed Web of Science ®Google Scholar
• Smiley, S. T., Reers M., Mottola-Hartshorn C., Lin M., Chen A., Smith T. W., Steele G. D., Jr., and Chen L. B.. 1991. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Natl. Acad. Sci. USA 88:3671–3675.
   PubMed Web of Science ®Google Scholar
• Strasser, A., Harris A. W., and Cory S.. 1991. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889–899.
   PubMed Web of Science ®Google Scholar
• Surh, C. D., and Sprent J.. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100–103.
   PubMed Web of Science ®Google Scholar
• Thornberry, N. A., Rano T. A., Peterson E. P., Rasper D. M., Timkey T., Garcia-Calvo M., Houtzager V. M., Nordstrom P. A., Roy S., Vaillancourt J. P., Chapman K. T., and Nicholson D. W.. 1997. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272:17907–17911.
   PubMed Web of Science ®Google Scholar
• Tibbetts, M. D., Zheng L., and Lenardo M. J.. 2003. The death effector domain protein family: regulators of cellular homeostasis. Nat. Immunol. 4:404–409.
   PubMed Web of Science ®Google Scholar
• Vande Velde, C., Cizeau J., Dubik D., Alimonti J., Brown T., Israels S., Hakem R., and Greenberg A. H.. 2000. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol. Cell. Biol. 20:5454–5468.
   PubMed Web of Science ®Google Scholar
• Van Hooijdonk, C. A., Glade C. P., and Van Erp P. E.. 1994. TO-PRO-3 iodide: a novel HeNe laser-excitable DNA stain as an alternative for propidium iodide in multiparameter flow cytometry. Cytometry 17:185–189.
   PubMedGoogle Scholar
• Vermes, I., Haanen C., Steffens-Nakken H., and Reutelingsperger C.. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184:39–51.
   Google Scholar
• Wenger, R. H. 2002. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 16:1151–1162.
   PubMed Web of Science ®Google Scholar
• Wiesener, M. S., Jurgensen J. S., Rosenberger C., Scholze C. K., Horstrup J. H., Warnecke C., Mandriota S., Bechmann I., Frei U. A., Pugh C. W., Ratcliffe P. J., Bachmann S., Maxwell P. H., and Eckardt K. U.. 2003. Widespread hypoxia-inducible expression of HIF-2α in distinct cell populations of different organs. FASEB J. 17:271–273.
   PubMed Web of Science ®Google Scholar